A game changer for cancer research?

Dr. Prabhu Arumugam, Director of Clinical Data and Imaging at Genomics England, and Torbjörn Kronander, President & CEO at Sectra, discuss the potential of genomics to provide more efficient processes, improving patient care.

About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2020/2021 fiscal year totaled SEK 1,632 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/.